Variable | Hazard ratio | 95% HR C.I. | p-value | |
---|---|---|---|---|
11-gene set, overall survival | ||||
 Median of risk score | 1.425 | 1.073 | 1.892 | 0.0143 |
 Gender | 1.460 | 0.926 | 2.300 | 0.1031 |
 Age | 1.037 | 1.022 | 1.052 | <0.0001 |
 Stage (0.1.2 vs. 3.4) | 2.990 | 2.185 | 4.092 | <0.0001 |
11-gene set, disease-free survival | ||||
 Median of risk score | 1.341 | 0.997 | 1.803 | 0.0521 |
 Gender | 1.485 | 0.930 | 2.371 | 0.0974 |
 Age | 1.036 | 1.020 | 1.051 | <0.0001 |
 Stage (0.1.2 vs. 3.4) | 2.941 | 2.116 | 4.087 | <0.0001 |
5-gene set, overall survival | ||||
 Median of risk score | 1.414 | 1.063 | 1.882 | 0.0172 |
 Gender | 1.455 | 0.923 | 2.293 | 0.1060 |
 Age | 1.037 | 1.022 | 1.052 | <0.0001 |
 Stage (0.1.2 vs. 3.4) | 2.922 | 2.134 | 3.999 | <0.0001 |
5-gene set, disease-free survival | ||||
 Median of risk score | 1.356 | 1.009 | 1.823 | 0.0435 |
 Gender | 1.489 | 0.933 | 2.375 | 0.0950 |
 Age | 1.036 | 1.021 | 1.051 | <0.0001 |
 Stage (0.1.2 vs. 3.4) | 2.903 | 2.087 | 4.037 | <0.0001 |